Document is current
Any future updates will be listed below
-
Authors
Sogorb-Esteve, Aitana
Nilsson, Johanna
Swift, Imogen J.
Heller, Carolin
Bocchetta, Martina
Russell, Lucy L.
Peakman, Georgia
Convery, Rhian S.
van Swieten, John C.
Seelaar, Harro
Borroni, Barbara
Galimberti, Daniela
Sanchez-Valle, Raquel
Laforce, Robert Jr.
Moreno, Fermin
Synofzik, Matthis
Graff, Caroline
Masellis, Mario
Tartaglia, Maria Carmela
Rowe, James B.
Vandenberghe, Rik
Finger, Elizabeth
Tagliavini, Fabrizio
Santana, Isabel
Butler, Chris R.
Ducharme, Simon
Gerhard, Alexander
Danek, Adrian
Levin, Johannes
Otto, Markus
Sorbi, Sandro
Le Ber, Isabelle
Pasquier, Florence
Gobom, Johan
Brinkmalm, Ann
Blennow, Kaj
Zetterberg, Henrik
Rohrer, Jonathan D.
,
Nelson, Annabel
Bouzigues, Arabella
Greaves, Caroline V
Cash, David
Thomas, David L
Todd, Emily
Benotmane, Hanya
Nicholas, Jennifer
Samra, Kiran
Shafei, Rachelle
Timberlake, Carolyn
Cope, Thomas
Rittman, Timothy
Benussi, Alberto
Premi, Enrico
Gasparotti, Roberto
Archetti, Silvana
Gazzina, Stefano
Cantoni, Valentina
Arighi, Andrea
Fenoglio, Chiara
Scarpini, Elio
Fumagalli, Giorgio
Borracci, Vittoria
Rossi, Giacomina
Giaccone, Giorgio
Di Fede, Giuseppe
Caroppo, Paola
Tiraboschi, Pietro
Prioni, Sara
Redaelli, Veronica
Tang-Wai, David
Rogaeva, Ekaterina
Castelo-Branco, Miguel
Freedman, Morris
Keren, Ron
Black, Sandra
Mitchell, Sara
Shoesmith, Christen
Bartha, Robart
Rademakers, Rosa
Poos, Jackie
Papma, Janne M.
Giannini, Lucia
van Minkelen, Rick
Pijnenburg, Yolande
Nacmias, Benedetta
Ferrari, Camilla
Polito, Cristina
Lombardi, Gemma
Bessi, Valentina
Veldsman, Michele
Andersson, Christin
Thonberg, Hakan
Öijerstedt, Linn
Jelic, Vesna
Thompson, Paul
Langheinrich, Tobias
Lladó, Albert
Antonell, Anna
Olives, Jaume
Balasa, Mircea
Bargalló, Nuria
Borrego-Ecija, Sergi
de Mendonça, Alexandre
Verdelho, Ana
Maruta, Carolina
Ferreira, Catarina B.
Miltenberger, Gabriel
do Couto, Frederico Simões
Gabilondo, Alazne
Gorostidi, Ana
Villanua, Jorge
Cañada, Marta
Tainta, Mikel
Zulaica, Miren
Barandiaran, Myriam
Alves, Patricia
Bender, Benjamin
Wilke, Carlo
Graf, Lisa
Vogels, Annick
Vandenbulcke, Mathieu
Van Damme, Philip
Bruffaerts, Rose
Poesen, Koen
Rosa-Neto, Pedro
Gauthier, Serge
Camuzat, Agnès
Brice, Alexis
Bertrand, Anne
Funkiewiez, Aurélie
Rinaldi, Daisy
Saracino, Dario
Colliot, Olivier
Sayah, Sabrina
Prix, Catharina
Wlasich, Elisabeth
Wagemann, Olivia
Loosli, Sandra
Schönecker, Sonja
Hoegen, Tobias
Lombardi, Jolina
Anderl-Straub, Sarah
Rollin, Adeline
Kuchcinski, Gregory
Bertoux, Maxime
Lebouvier, Thibaud
Deramecourt, Vincent
Santiago, Beatriz
Duro, Diana
Leitão, Maria João
Almeida, Maria Rosario
Tábuas-Pereira, Miguel
Afonso, Sónia
- License Information
-
More Information
Article History
Received: 23 February 2022
Accepted: 6 July 2022
First Online: 31 August 2022
Declarations
:
: The study was reviewed and approved by all countries’ respective ethics committees, and all participants signed an informed consent to take part in the research. The participating centres in the GENFI study are University College London, Erasmus Medical Centre, University of Brescia, University of Milan, University of Barcelona, Université Laval, Donostia University Hospital, University of Tübingen, Karolinska Institutet, University of Toronto, University of Cambridge, University Hospitals Leuven, University of Western Ontario, Fondazione IRCCS Instituto Neurologico Carlo Besta, University of Coimbra, University of Oxford, McGill University, University of Manchester, LMU Klinikum, University of ULM IRCCSS Fondazione Don Carlo Gnocchi, Sorbonne Université, and University of Lille.Consent for publication.Not applicable.
: KB has served as a consultant, at advisory boards or at data monitoring committees, for Abcam, Axon, BioArctic, Biogen, JOMDD/Shimadzu, Julius Clinical, Lilly, MagQu, Novartis, Pharmatrophix, Prothena, Roche Diagnostics, and Siemens Healthineer, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program, outside the work presented in this paper. HZ has served at scientific advisory boards and/or as a consultant for Abbvie, Alector, Annexon, Artery Therapeutics, AZTherapies, CogRx, Denali, Eisai, Nervgen, Pinteon Therapeutics, Red Abbey Labs, Passage Bio, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave; has given lectures in symposia sponsored by Cellectricon, Fujirebio, Alzecure, Biogen, and Roche; and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program. JDR has served as a consultant or on an advisory board for Alector, Prevail Therapeutics, Denali, Arkuda Therapeutics, Takeda, UCB, Wave Life Sciences, and Novartis. The other authors declare that they have no competing interests.
